J&J PALMAZ-SCHATZ CORONARY STENT PHYSICIAN TRAINING BEGINNING
This article was originally published in The Gray Sheet
Executive SummaryJ&J PALMAZ-SCHATZ CORONARY STENT PHYSICIAN TRAINING BEGINNING following FDA approval of the device on Aug. 2. Shipments of the device, which is indicated for use in selected patients with coronary artery disease who are eligible for balloon angioplasty, are expected to begin after the training program goes into full swing.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.